Taho Pharmaceuticals Ltd.

Industry-academic Cooperation Foundation

Nal Pharmaceuticals, Ltd.

Industry-Academic Cooperation Foundation, Chosun University

Nal Pharmaceutical Group Limited

Golden Pacific Bio Limited

Hoo-kyun Choi

Myung-kwan Chun

Y Joseph Mo

The present invention provides a transdermal delivery system, which comprises a drug-containing matrix layer comprising: galantamine or its pharmaceutically acceptable salt as an active ingredient; and a styrene-butadiene-styrene copolymer or a styrene-isoprene-styrene copolymer as an adhesive.

Transdermal delivery system containing galantamine or salts thereof

The present invention provides a transdermal drug delivery system comprising a drug-containing matrix layer comprising: (a) donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; and (b) an acrylate-rubber hybrid as an adhesive.

Transdermal drug delivery system containing donepezil

Disclosed herein is a transdermal system in a matrix form capable of enhancing granisetron carrying efficiency and improving transdermal absorption while inhibiting recrystallization, which comprises: at least one transdermal enhancer selected from a group consisting of polyglyceryl-3 oleate, polyethyleneglycol-20 almond glyceride, polyethyleneglycol-12 palm kernel glyceride, isopropyl myristate and oleyl alcohol; and an acrylate polymer.

Transdermal drug delivery system containing granisetron

Growing community of inventors

Gwangju, South Korea

Hoo-kyun Choi